Cirka halvdelen af patienterne havde præstationskapacitet svarende til ECOG 0, og halvdelen af patienterne var i den lave MSKCC- prognosegruppe.
Approximately half of the patients had an ECOG performance status of 0, and half of the patients were in the low risk MSKCC prognostic group.